AIRLINK 217.40 Decreased By ▼ -0.58 (-0.27%)
BOP 10.73 Decreased By ▼ -0.20 (-1.83%)
CNERGY 7.33 Decreased By ▼ -0.22 (-2.91%)
FCCL 34.25 Decreased By ▼ -0.58 (-1.67%)
FFL 19.25 Decreased By ▼ -0.07 (-0.36%)
FLYNG 24.95 Decreased By ▼ -0.20 (-0.8%)
HUBC 130.68 Decreased By ▼ -0.41 (-0.31%)
HUMNL 14.36 Decreased By ▼ -0.20 (-1.37%)
KEL 5.25 Increased By ▲ 0.07 (1.35%)
KOSM 7.40 Increased By ▲ 0.04 (0.54%)
MLCF 45.30 Decreased By ▼ -0.33 (-0.72%)
OGDC 220.35 Decreased By ▼ -1.73 (-0.78%)
PACE 8.58 Increased By ▲ 0.42 (5.15%)
PAEL 44.30 Increased By ▲ 0.11 (0.25%)
PIAHCLA 17.80 Increased By ▲ 0.11 (0.62%)
PIBTL 9.07 Increased By ▲ 0.10 (1.11%)
POWERPS 12.51 Decreased By ▼ -0.50 (-3.84%)
PPL 191.44 Decreased By ▼ -1.57 (-0.81%)
PRL 41.60 Decreased By ▼ -1.57 (-3.64%)
PTC 26.63 No Change ▼ 0.00 (0%)
SEARL 107.51 Increased By ▲ 0.43 (0.4%)
SILK 1.03 Decreased By ▼ -0.01 (-0.96%)
SSGC 44.78 Decreased By ▼ -0.22 (-0.49%)
SYM 21.20 Increased By ▲ 0.01 (0.05%)
TELE 10.35 Increased By ▲ 0.20 (1.97%)
TPLP 14.56 Increased By ▲ 0.05 (0.34%)
TRG 67.35 Increased By ▲ 0.07 (0.1%)
WAVESAPP 11.40 Increased By ▲ 0.11 (0.97%)
WTL 1.74 Increased By ▲ 0.04 (2.35%)
YOUW 4.26 Increased By ▲ 0.01 (0.24%)
BR100 12,362 Decreased By -34.7 (-0.28%)
BR30 37,237 Decreased By -110.1 (-0.29%)
KSE100 117,760 Increased By 172.8 (0.15%)
KSE30 37,094 Increased By 28.5 (0.08%)

EFU Life Assurance Ltd announced that the Offer and Bid prices for the following funds effective from March 02, 2009.



============================
EFU Managed Growth Fund
============================
Offer price Rs 603.99
Bid price Rs 573.79
============================
EFU Pension Growth Fund
============================
Offer price Rs 112.89
Bid price Rs 107.24
============================
EFU Capital Growth Fund
============================
Offer price Rs 192.84
Bid Price Rs 183.19
============================
EFU Aitemad Growth Fund
============================
Offer price Rs 506.68
Bid Price Rs 481.34
============================

Copyright Business Recorder, 2009

Comments

Comments are closed.